Document
IPR2015-01980, No. 1061 Exhibit - AMNEAL 1061 httpwwwaccessdatafdagovscriptscderobdocspatexclnewcfmApplNo020622ProductNo003table1OBRx accessed February 5, 2015 (P.T.A.B. S...
Cite Document
IPR2015-01980, No. 1061 Exhibit - AMNEAL 1061 httpwwwaccessdatafdagovscriptscderobdocspatexclnewcfmApplNo020622ProductNo003table1OBRx accessed February 5, 2015 (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1005 Exhibit - AMNEAL 1005 Irit Pinchasi International Publication No WO 2007081975 (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1005 Exhibit - AMNEAL 1005 Irit Pinchasi International Publication No WO 2007081975 (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1016 Exhibit - AMNEAL 1016 MB Bornstein et al, A Pilot Trial of COP 1 in Exacerbating Remitting Multiple Sclerosis (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1016 Exhibit - AMNEAL 1016 MB Bornstein et al, A Pilot Trial of COP 1 in Exacerbating Remitting Multiple Sclerosis (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1015 Exhibit - AMNEAL 1015 MB Bornstein et al, Clinical Trial of Copolymer I in Multiple Sclerosis (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1015 Exhibit - AMNEAL 1015 MB Bornstein et al, Clinical Trial of Copolymer I in Multiple Sclerosis (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1021 Exhibit - AMNEAL 1021 Leslie Z Benet et al, Pharmacokinetics The Dynamics of Drug Absorption, Distribution, and Elimination (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1021 Exhibit - AMNEAL 1021 Leslie Z Benet et al, Pharmacokinetics The Dynamics of Drug Absorption, Distribution, and Elimination (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1059 Exhibit - AMNEAL 1059 FDA Guidance For Industry Population Pharmacokinetics 1999 (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1059 Exhibit - AMNEAL 1059 FDA Guidance For Industry Population Pharmacokinetics 1999 (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1032 Exhibit - AMNEAL 1032 Stuart, Clinical management of multiple sclerosis The treatment paradigm and issues of patient management (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1032 Exhibit - AMNEAL 1032 Stuart, Clinical management of multiple sclerosis The treatment paradigm and issues of patient management (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1009 Exhibit - AMNEAL 1009 Zeev Meiner et al, Copolymer 1 in relapsing remitting multiple sclerosis a multi centre trial (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1009 Exhibit - AMNEAL 1009 Zeev Meiner et al, Copolymer 1 in relapsing remitting multiple sclerosis a multi centre trial (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1001 Exhibit - AMNEAL 1001 US Patent No 8,399,413 (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1001 Exhibit - AMNEAL 1001 US Patent No 8,399,413 (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1062 Exhibit - AMNEAL 1062 httpsscamparoowordpresscom20080411mstherapiescopaxonedated April 11, 2008 accessed February 5, 2015 (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1062 Exhibit - AMNEAL 1062 httpsscamparoowordpresscom20080411mstherapiescopaxonedated April 11, 2008 accessed February 5, 2015 (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1004 Exhibit - AMNEAL 1004 Expert Declaration of, Curriculum Vitae of, and Materials Reviewed by Ari Green, MD (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1004 Exhibit - AMNEAL 1004 Expert Declaration of, Curriculum Vitae of, and Materials Reviewed by Ari Green, MD (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1020 Exhibit - AMNEAL 1020 Ruth Arnon, The development of Cop 1 Copaxone, an innovative drug for the treatment of multiple sclerosis (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1020 Exhibit - AMNEAL 1020 Ruth Arnon, The development of Cop 1 Copaxone, an innovative drug for the treatment of multiple sclerosis (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1040 Exhibit - AMNEAL 1040 JJ Kragt et al, How similar are commonly combined criteria for EDSS progression in multiple sclerosis (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1040 Exhibit - AMNEAL 1040 JJ Kragt et al, How similar are commonly combined criteria for EDSS progression in multiple sclerosis (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1046 Exhibit - AMNEAL 1046 Teva Provides Update on Forte Trial Jerusalem, Israel (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1046 Exhibit - AMNEAL 1046 Teva Provides Update on Forte Trial Jerusalem, Israel (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1037 Exhibit - AMNEAL 1037 Devonshire et al, The Global Adherence Project A multicentre observational study on adherence to disease modifying therapies in patients suf...
Cite Document
IPR2015-01980, No. 1037 Exhibit - AMNEAL 1037 Devonshire et al, The Global Adherence Project A multicentre observational study on adherence to disease modifying therapies in patients suffering from re
+ More Snippets